EUVIMEDEUVIMED entdecken
Open Access

The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure

David S Umbaugh iD, Nga T Nguyen iD, Steven C Curry, Jody A Rule, William M Lee, Anup Ramachandran iD, Hartmut Jaeschke iD, Acute Liver Failure Study Group

Toxicological Sciences · 2025

DOI: 10.1093/toxsci/kfaf130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von David S Umbaugh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, United States. Hauptthemen laut MEDLINE: Acetaminophen, Angiopoietin-2, Liver Failure, Acute, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP) overdose is the leading cause of acute liver failure (ALF) in the United States, with many patients rapidly progressing to hyperacute liver failure. Although hepatocytes are the main target of APAP toxicity, endothelial cells (ECs) are also affected. However, the efficacy of an endothelial-specific biomarker to predict patient outcomes remains unknown. This study aimed to evaluate angiopoietin-2 (ANGPT2) as a prognostic biomarker for poor outcomes in APAP-induced ALF. Using human and mouse single-cell RNA-sequencing data, we found that ANGPT2 expression was significantly elevated in ECs following APAP exposure. We measured circulating ANGPT2 levels in 2 independent APAP-ALF cohorts: A cohort from Phoenix (n = 43) and the ALF Study Group (n = 80). In the Phoenix cohort, ANGPT2 levels were significantly higher in nonsurvivors with an area under the receiver-operating characteristic curve of 0.938. In the ALF Study Group cohort, we stratified patients based on time of symptom onset, finding that ANGPT2 had improved prognostic value in early-presenting patients, with Day 1 and 3 AUC values of 0.825 and 0.918, respectively. Lastly, we combined the patient cohorts (n = 110), finding that ANGPT2 alone or in combination with Model for End-Stage Liver Disease (MELD) score outperformed MELD alone based on AUC (ANGPT2: 0.87, MELD: 0.83, ANGPT2+MELD: 0.90). Conclusions: ANGPT2 is a promising prognostic biomarker for APAP-induced ALF, reflecting endothelial stress and offering superior predictive value compared with MELD alone, especially in early-presenting patients. Its capacity for predicting poor outcomes underscores its value in improving patient prognosis and therapeutic intervention strategies in APAP overdose cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenAngiopoietin-2Liver Failure, AcuteChemical and Drug Induced Liver InjuryAnalgesics, Non-NarcoticHumansBiomarkersMaleFemalePrognosisAdultMiddle AgedAnimalsMiceEndothelial Cells

Stichwörter der Autor:innen

acetaminophen-induced liver injurybiomarkersdrug hepatotoxicitysingle-cell RNA-sequencing

Substanzen

AcetaminophenAngiopoietin-2BiomarkersANGPT2 protein, humanAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, United States.
  • Department of Medical Toxicology, Banner-University Medical Center Phoenix, Phoenix, AZ, 85006, United States.
  • Department of Medicine, and Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, 85006, United States.
  • Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX, 75235, United States.

ORCID-Profile: David S Umbaugh, Nga T Nguyen, Anup Ramachandran, Hartmut Jaeschke

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • KUMC Research Administration
  • NLM NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of General Medical Sciences
  • Liver Disease COBRE

Zitieren

APA

Umbaugh, D. S., Nguyen, N. T., Curry, S. C., Rule, J. A., Lee, W. M., Ramachandran, A., Jaeschke, H., & Acute Liver Failure Study Group (2025). The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf130

Vancouver

Umbaugh DS, Nguyen NT, Curry SC, Rule JA, Lee WM, Ramachandran A, et al. The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf130

BibTeX
@article{Umbaugh2025,
  author = {Umbaugh, David S and Nguyen, Nga T and Curry, Steven C and Rule, Jody A and Lee, William M and Ramachandran, Anup and Jaeschke, Hartmut and Acute Liver Failure Study Group, Acute Liver Failure Study Group},
  title = {The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure},
  journal = {Toxicological Sciences},
  year = {2025},
  doi = {10.1093/toxsci/kfaf130}
}
Kostenlos starten →